Pylarify piflufolastat F18 injection
Ended Awarded Last action
- Contract number
- 36C24624N0451
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $717,727
Award facts
- Contract value 100% obligated
- $717,726.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$220,541 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $938,267 |
About this award
This is a $717,726.56 firm-fixed-price delivery order awarded to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract is for the provision of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The award was made by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of April 4, 2025. Lantheus Holdings, Inc., the parent company of Progenics Pharmaceuticals, is a prominent manufacturer of diagnostic medical imaging agents and radiopharmaceuticals that has established itself as a critical supplier of these specialized products to federal healthcare providers, particularly the VA and Defense Health Agency. This delivery order is not designated as a small business set-aside.
Quick answers
Who was awarded contract 36C24624N0451?
36C24624N0451 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on February 2, 2024.
How much is contract 36C24624N0451 worth?
The government has obligated $717,727 on 36C24624N0451.
Is contract 36C24624N0451 an order under another contract?
Yes. 36C24624N0451 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24624N0451 competed?
The extent of competition for 36C24624N0451 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award